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PURPOSE. We investigated whether subthreshold retinal phototherapy (SRPT) was associated
with recruitment of bone marrow (BM)–derived cells to the neurosensory retina (NSR) and
RPE layer.
METHODS. GFP chimeric mice and wild-type (WT) mice were subjected to SRPT using a slit-
lamp infrared laser. Duty cycles of 5%, 10%, 15%, and 20% (0.1 seconds, 250 mW, spot size 50
lm) with 30 applications were placed 50 to 100 lm from the optic disc. In adoptive transfer
studies, GFPþ cells were given intravenously immediately after WT mice received SRPT.
Immunohistochemistry was done for ionized calcium-binding adapter molecule-1 (IBA-1þ),
CD45, Griffonia simplicifolia lectin isolectin B4, GFP or cytokeratin). Expression of Ccl2, Il1b,
Il6, Hspa1a, Hsp90aa1, Cryab, Hif1a, Cxcl12, and Cxcr4 mRNA and flow cytometry of the
NSR and RPE-choroid were performed.
RESULTS. Within 12 to 24 hours of SRPT, monocytes were detected in the NSR and RPE-
choroid. Detection of reparative progenitors in the RPE occurred at 2 weeks using flow
cytometry. Recruitment of GFPþ cells to the RPE layer occurred in a duty cycle–dependent
manner in chimeric mice and in mice undergoing adoptive transfer. Hspa1a, Hsp90aa1, and
Cryab mRNAs increased in the NSR at 2 hours post laser; Hif1a, Cxcl12, Hspa1a increased at
4 hours in the RPE-choroid; and Ccl2, Il1b, Ifng, and Il6 increased at 12 to 24 hours in the
RPE-choroid.
CONCLUSIONS. SRPT induces monocyte recruitment to the RPE followed by hematopoietic
progenitor cell homing at 2 weeks. Recruitment occurs in a duty cycle–dependent manner
and potentially could contribute to the therapeutic efficacy of SRPT.
Keywords: micropulse, subthreshold, macular edema
AMD is the most common cause of blindness in the Westernworld. As a consequence, this disease is considered a major
public health problem. Approximately 85% to 90% of individ-
uals have the nonexudative form of AMD. This consists of RPE
loss, atrophy, and depigmentation. With the exception of
dietary supplements, there is no effective treatment avail-
able.1,2 New therapies are therefore urgently required to treat
this rapidly growing population of individuals. One therapeutic
approach not yet fully evaluated for nonexudative AMD is
cellular therapeutics. The bone marrow (BM) is an accessible
source of progenitor cells and reparative cells.3–6 These cells
can home to areas of injury, participate with resident cells in
repair of diseased tissues, and when in the circulation, are
amenable to both hormonal and pharmacological manipulation.
In earlier studies, using GFP chimeric mice in the laser-induced
model of choroidal neovascularization (CNV), we demonstrated
recruitment of BM cells to areas of damaged retina and
choroid.7–9 Using sodium iodate to induce RPE injury, we
demonstrated that BM-derived cells are mobilized to the RPE
layer and associate with the remaining RPE cells to promote
proper RPE repair.8,10
BM stem/progenitor cells have been used to treat individuals
with retinal or neurologic diseases.11–14 The major protective
mechanism of these cells is their paracrine secretion of factors
with anti-inflammatory, antiapoptotic, proliferative, and proan-
giogenic actions.15,16 However, the BM is also a source of
inflammatory cells, which can infiltrate into the retina or brain
parenchyma in response to alterations that may occur after
injury.17–21 Proinflammatory cells can contribute to both
physiological repair and pathophysiological events, including
cytokine release.22 Extravasation of BM-derived cells into the
central nervous system and the retina contribute to the
generation of microglia identified using IBA-1 immunohisto-
chemistry. Typically at the site of injury, the number of
microglia that originates from BM increases dramatically after
tissue damage.23 We have observed this paradigm for retinal
damage induced by diabetes.19,24–27 The capacity of microglial
precursors to cross the blood–brain barrier and home to sites of
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neural damage and inflammation makes these cells particularly
useful for therapeutic strategies in the retina and brain.
Continuous wave (CW) thermal lasers have long been
important tools for the treatment of various retinal disor-
ders.28–33 Their therapeutic efficacy in the treatment of
diabetic macular edema (DME) is well-established but at the
expense of potentially serious side effects such as development
of scotomata, subretinal scarring, and CNV, all resulting from
thermal-induced damage to the outer retina, RPE, and Bruch’s
membrane.30,34–41 However, the precise mechanism of action
of CW laser has yet to be fully delineated.42–51
Recently developed to minimize photothermal damage to
the retina and adjacent structures, micropulse laser induces
photochemical injury.52–56 In this study, we investigated the
migration and microglial nature of BM-derived cells present in
the neurosensory retina (NSR) and RPE-choroid at various time
points after subthreshold retinal phototherapy (SRPT) using
various duty cycles (DCs).
METHODS
Animals
All animal studies were approved by the Institutional Animal
Care and Use Committee at the University of Florida and
Indiana University, and studies were conducted in accordance
with the principles described in the ARVO Statement for the
Use of Animals in Ophthalmic and Vision Research.
To facilitate the identification of BM-derived cells, GFP BM
chimeric mice were generated. Adult (12 weeks) C57BL-6J
female mice were irradiated (950 rads) to ablate their BM.
Immediately after irradiation, they were given 10,000 cKitþSca-
1þ BM stem cells obtained from 12-week-old male C57BL/6-Tg
(ACTB-EGFP) transgenic mice as previously described.9 Ani-
mals were assessed for BM reconstitution 4 weeks after
transplant by determining the percentage of peripheral blood
leukocytes (PBLs) expressing GFP. Those animals with at least
80% of PBLs positive for GFP were considered fully reconsti-
tuted and used for subsequent experiments.
BM Cell Recruitment Following SRPT
We assessed the degree of microglial activation in the retina by
measuring the relative expression of IBA-1 (a marker for
microglia) at various times following SRPT. Each mouse
received 10% DC SRPT in one eye for 0.1 seconds at 250
mW and a spot size set to 50 lm. Thirty applications were
administered to each eye circumferentially placed between 50
and 100 lm from the optic disc. Eyes were then harvested at 0
(control, no laser), 12 hours, 24 hours, and 2 weeks (n ¼ 5
animals per time point and repeated in triplicate). Harvested
eyes were dehydrated, embedded in paraffin, and sectioned (6-
lm sections, collecting every third section). After deparaffina-
tion, the sections were incubated with goat anti–IBA-1 (Wako,
Richmond, VA, USA) followed by Alexa Fluor 647–conjugated
second antibody (Abcam, Cambridge, MA, USA), mounted with
DAPI antifade medium (Vector Laboratories, Burlingame, VT,
USA), and imaged using a Leica laser scanning spectral confocal
microscope (TCS-SP2; Leica, Buffalo Grove, IL, USA).
Another set of eyes from wild-type (WT) mice was fixed in
buffered 4% (wt/vol) paraformaldehyde overnight at 48C, then
washed by immersion in two changes of PBS before dissection.
Neural retina was discarded, and posterior segment was
permeabilized and blocked overnight at 48C in PBS containing
0.3% (vol/vol) Triton X-100 and 0.2% (wt/vol) bovine serum
albumin (Sigma-Aldrich Corp., St. Louis, MO, USA) and 5% goat
serum in 10 mM HEPES buffer. Samples were then incubated
overnight at 48C in either rabbit anti-Occludin (Zymed, South
San Francisco, CA, USA) diluted 1:50; rat anti-CD45 (Novus
Biologicals, Littleton, CO, USA) diluted 1:10; or fluorescein-
labeled Griffonia simplicifolia lectin isolectin B4 (Vector
Laboratories) in blocking buffer. After washes in two changes
of PBS, samples were incubated in goat anti-rabbit Dylight 649
(Abcam) diluted 1:200 and/or goat anti-rat Dylight 488
(ThermoFisher, Waltham, MA, USA) diluted 1:200 for 4 hours
at 48C. After performing five radial incisions, posterior
segments were flat-mounted on a glass slide, and antifade
medium (Vectashield; Vector Laboratories) and glass coverslips
were applied. Digital image captures (~3 lm z-depth) were
made using a laser scanning confocal microscope Z-series
captures (Zeiss, Thornwood, NY, USA).
Preparation of NSR and RPE—Choroid Into a
Single-Cell Suspension
From representative eyes, the NSR and the RPE-choroid were
dissected and placed in RPMI-1640 (Sigma-Aldrich Corp.)
supplemented with 5% fetal bovine serum (FBS). NSRs were
then digested in 1 mL RPMI-5% FBS with 0.5 mg/mL
collagenase D (Roche, Indianapolis, IN, USA) and 250 lg/mL
DNAse (Sigma-Aldrich Corp.) for 30 minutes at 378C after
disrupting the tissue with a pipette in a microcentrifuge tube.
RPE-choroid was digested in 1 mL RPMI-5% FBS with 0.5 mg/
mL collagenase D and 250 lg/mL DNAse for 30 minutes at 378C
after cutting the tissue with scissors. Single-cell suspensions
were generated, and the digested tissue segments were passed
through a 70-lm cell strainer with the plunger of a 3-mL
syringe. Cells were washed twice with PBS-2% FBS supple-
mented with 1 mM EDTA (fluorescence-activated cell sorting
[FACS] buffer). The single-cell suspensions of NSR and RPE-
choroid from each eye were stained with antibodies for flow
cytometry as described in the following sections.
Flow Cytometry and FACS Analysis
Cells were incubated for 10 minutes on ice with 20 lg/mL
TruStain fcX 93 (Biolegend, San Diego, CA, USA) for
nonspecific binding. Subsequently, cells were stained for 30
minutes and placed on ice with combinations of the following
antibodies: (1) for myeloid cells: FITC-Ly6C, HK1.4 (Biole-
gend); PE-Ly6G, 1A8; PECy7-CD11c, HL3; PE-CF594-CD11b,
M1/70; Alexa Fluor 700-CD45, 30-F11; V500-CD3e, 500A2; BV-
421-NK1.1, PK136 (BD Bioscience, San Jose, CA, USA); APC-
F4/80, BM8; PerCP-eFluor710-CD115, AFS98 (eBioscience, San
Diego, CA, USA); (2) for progenitor cells: FITC-CD117, 2B8
(eBioscience); PE-CD34, MEC14.7; PECy7-Ly6A/E, D7; BV-421-
Lineage cocktail (Biolegend); Alexa Fluor 700-CD45, 30-F11
(BD Bioscience). Samples were washed once with FACS buffer,
then with PBS, stained for 30 minutes, and placed on ice with
APCefluor780-fixable/viability dye (eBioscience) for live/dead
cell discrimination. After two more washes, cells were fixed
with 1% formalin and acquired on a LSR Fortessa (BD
Bioscience) flow cytometer (at the flow cytometry facility of
Indiana University School of Medicine, Indianapolis, IN, USA).
All cells (events) inside each tube were acquired for each
sample to represent the total amount of cells per sample.
CD45hi and microglia cell numbers represent the total events
acquired by flow cytometry in their respective gates of each
sample. Data were analyzed using FlowJo 10.2 software
(FlowJo, Ashland, OR, USA).
Varying DC of SRPT in GFPþ Chimeric Mice
GFP BM reconstituted mice were subjected to SRPT in one eye
using an infrared laser (Iridex OcuLight SLx MicroPulse 810
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nm; IRIDEX, Mountain View, CA, USA) coupled to a slit-lamp.
Variable DCs of 5%, 10%, 15%, and 20% (n ¼ 5 animals each
duty cycle) were used for 0.1 second at 250 mW and a spot size
set to 50 lm. Thirty applications were administered to each
eye circumferentially placed between 50 and 100 lm from the
optic disc. An additional cohort of five WT age- and gender-
matched animals did not receive SRPT, and those eyes were
used as controls.
Two weeks later, eyes were harvested. The posterior
segments were reacted with rabbit anti-cytokeratin (1:400; Dako
A/S, Glostrup, Denmark), followed by an Alexa Fluor 488 goat
anti-rabbit antibody (1:200; Abcam) used as the secondary. Slides
were counterstained with DAPI. Posterior segments were
mounted flat using four to five radial cuts and were then
examined using an upright fluorescent microscope (DM2500;
Leica). The area positive for eGFP was quantified using ImageJ
software (http://imagej.nih.gov/ij/; provided in the public
domain by the National Institutes of Health, Bethesda, MD, USA).
Adoptive Transfer of BM Stem Cells Following
SRPT
Five WT mice were treated with 10% DC SRPT and then
immediately given 15,000 cKitþ Sca-1þ BM cells from a GFPþ/þ
donor via IV injection. Two weeks later the eyes were harvested,
preserved, and cryosectioned. Sections were reacted with Alexa
Fluor 488 goat anti-rabbit antibody, counterstained with DAPI,
mounted, and examined as described.
Time Course and Tissue-Compartment Changes in
Heat Shock Proteins (HSP), Cxcl12, and Cxcr4
Involved in Cell Recruitment
To identify the possible mechanism for the SRPT-induced BM-
derived cell recruitment to the NSR and RPE-choroid, we
measured mRNA levels of HSP Hspa1a and Hsp90aa1 and the
known homing factor Cxcl12 and its receptor Cxcr4. One eye
(n¼ 5 per time point) of GFP chimeric mice was subjected to
10% DC SRPT. Mice were euthanized 2, 4, and 12 hours after
SRPT application. Eyes from an additional cohort of five
animals that did not receive SRPT served as controls. Eyes were
dissected and the NSR and PC were separately homogenized in
Trizol reagent (Invitrogen, Waltham, MA, USA), and RNA was
isolated according to the manufacturer’s instructions. First-
strand cDNA was synthesized using SuperScript II reverse
transcription (Invitrogen). Prepared cDNA was mixed with 23
SYBR Green PCR Master Mix (Applied Biosystems, Waltham,
MA, USA) and appropriate gene-specific forward and reverse
primers, then was subjected to real-time PCR quantification
using the ABI PRISM 7700 Sequence Detection System
(Applied Biosystems). All reactions were performed in
triplicate. The relative amounts of mRNAs were calculated
using the comparative threshold cycle method. All results were
normalized to the abundance of Actb, which was used as
endogenous control.
Time Course and Tissue-Compartment Changes in
mRNA of Cytokines
The expression of inflammatory cytokines was examined in
WT mice undergoing SRPT. For total RNA isolation, the RNeasy
Mini Kit (Qiagen, Valencia, CA, USA) was used. One NSR and
one RPE-choroid per sample were separately disrupted in 350
lL of lysis buffer with the TissueLyser LT (Qiagen) for 2 3 1
minute, using three to five 1-mm and twelve 3-mm zirconium
oxide/yttria-stabilized beads (Union Process, Akron, OH, USA).
The supernatants were further processed in a QIAcube
(Qiagen) with the RNeasy Mini Kit. RNA quantity and quality
was determined with NanoDrop 2000C (Thermo Scientific).
For the reverse transcription, the SuperScript VILO cDNA
Synthesis Kit (Thermo Scientific) was used according to
manufacturer protocol, starting from 200 ng total RNA. For
the PCR step, BioRad (Hercules, CA, USA) reagents were used
as follows: primer sets for Cryab, Hif1a, Tnfa, Il1b, Il6,
Cxcl12, Ccl2, and Ifng, and as endogenous control, Actb, as
well as the SsoAdvanced Universal SYBR Green Supermix. The
real-time PCR was performed in a ViiA7 Real-Time PCR System
(Thermo Scientific) according to BioRad’s suggested settings.
Statistical Analysis
Data were analyzed using GraphPad Prism 6.0 (GraphPad
Software, La Jolla, CA, USA). One-way ANOVA was applied.
Multiple comparisons were performed among all groups, with
P  0.05 considered significant.
RESULTS
SRPT Does Not Disrupt the NSR or RPE Layer
The NSR and RPE layer were examined for evidence of damage
following SRPT. As shown in Figure 1A–D, a time course study
was performed in WT mice exposed to SRPT and euthanized at
12 hours, 24 hours, and 2 weeks following SRPT. No histologic
evidence of NSR or RPE injury was observed in the experimental
cohorts, and IBAþ cells were observed in the NSR (Fig. 1).
Phenotypic and Time Course Characterization of
the BM-Derived Cells That Home to the NSR and
RPE
Characterization of the BM cells that homed to the retina was
performed using flow cytometry. A significant increase in the
total number of hematopoietic cells (CD45hi cells) recruited to
the NSR was observed 2 weeks following SRPT. The number of
microglia was similarly increased at this time point (Fig. 2A).
Temporal changes were observed in the content of infiltrating
cells, especially at 24 hours post laser. A reduction of the
percentage of lymphocytes was observed for T cells and other
CD11b cells and an increase in the percentage of monocytes
(Fig. 2B), especially the inflammatory, Ly6Chi cells (Fig. 2C).
Neutrophil, dendritic cells, or macrophage percentages re-
mained similar postlaser treatment.
In the RPE-choroid, we observed no significant increase in
the total number of CD45hi hematopoietic cells at any of the
time points, and microglia were only increased at 2 weeks
compared to 24 hours (Fig. 3A), although their abundance was
very low compared to NSR. The composition of infiltrating
CD45hi in the RPE-choroid, in contrast to the NSR, changed
significantly after laser treatment toward a more proinflamma-
tory profile. As shown in Figure 3B, neutrophils were increased
significantly within the first 24 hours, with a similar infiltration
of monocytes. Among lymphocytes, T cells did not change
significantly, but CD11b cells were increased at 2 weeks;
these cells could be B cells, natural killer cells, or progenitor
cells, but not myeloid cells. Macrophages were increased at 2
weeks (Fig. 3B), indicating differentiation of infiltrating
monocytes. The temporal increase in monocytes was in the
Ly6Chi population (Fig. 3C).
Because we observed an increase in CD11 cells in the RPE-
choroid, we examined by flow cytometry the stem/progenitor
cells recruited to the NSR and the RPE-choroid. In Figure 4,
time-dependent changes are shown in the recruitment of
progenitor cells, especially the Lin Sca-1þ (LS). In contrast, we
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did not observe any recruitment of the Lin c-kitþ or the Lin
Sca-1þ c-kitþ. LS cells were increased in the NSR, but not the
RPE-choroid at 2 weeks post SRPT.
BM Cells Localization Following SRPT
Using GFP chimeric mice to more easily quantify the number
of BM cells that home to the posterior cup, we next examined
the impact of DC on the number and localization of GFPþ cells.
While a low number of GFPþ cells were seen in the control
chimeric animals, a robust recruitment of GFPþ cells was
observed in regions of laser-stimulated RPE 2 weeks following
SRPT. We observed a DC-dependent homing of GFPþ cells with
a maximal response at 10% DC (Fig. 5A, B).
Using WT mice, we performed a short-term study. At time
zero, there was no evidence of infiltration of BM-derived cells
(Fig. 5C). However, 12 hours post SRPT, BM cells (Isolectin-B4
positive)57–59 appeared to home to the RPE layer (Fig. 5D).
Utilizing a second marker for BM cells, CD45, we observed and
confirmed the association of BM cells with the RPE layer (Fig.
5E) at 12 hours post SRPT.
Exogenous BM Stem Cells Administered by
Adoptive Transfer Localized to the RPE Layer
BM stem/progenitor cells can be isolated and introduced
intravenously by a technique called adoptive transfer. WT mice
received intravenous BM stem cells from GFP transgenic mice
immediately after receiving 10% DC subthreshold micropulse
laser. Eyes were harvested 2 weeks later and examined for
expression of GFP. GFP cells were found that homed to and
localized to the RPE layer (Fig. 6).
Micropulse Laser Induces a Time- and Tissue
Compartment–Dependent Change in mRNA
Expression of Key Protective Proteins and
Molecular Chaperones
To identify the possible mechanism for the micropulse laser–
induced BM-derived cell recruitment to the retina, we
measured the time course of mRNA levels of the Hspa1a and
Hsp90aa1 and Cryab, after using a diode laser (810 nM) and
10% DC. A peak increase in Hspa1a was observed 2 hours post
laser in the NSR and at 4 hours in RPE-choroid (Fig. 7A). At 2
hours, mRNA for Hsp90aa1 dramatically peaked in both the
NSR and the RPE-choroid (Fig. 7B). Cryab showed a marked
increase at 2 hours in the NSR but a decrease at 12 hours in the
NSR. In contrast, the levels of Cryab in the RPE-choroid
showed a decrease at 2 and 4 hours (Fig. 7C).
Following SRPT, we observed that Hif1a mRNA (Fig. 7D)
was reduced at 2 hours in both the NSR and the RPE-choroid,
but increased above baseline in the RPE-choroid at 4 hours.
Since the BM cell homing factor, CXCL-12 (or stromal-derived
FIGURE 1. Subthreshold micropulse laser stimulates IBA-1þ cell activation in the neural retina of WT mice in a time-dependent manner. (A–D)
Representative images of frozen sections from eyes receiving 10% DC subthreshold micropulse laser and harvested at 0 (control, no laser) (A), 12
hours (B), 24 hours (C), and 2 weeks (D), respectively. Scale bar: In D¼ 40 lm and applies to all micrograph panels.
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FIGURE 2. Time-dependent changes in the recruitment of BM-derived CD45hi cells in the NSR. Mouse eyes were subjected to 10% DC subthreshold
micropulse laser. Eyes were harvested and retinas were prepared for flow cytometry. (A) Percentages of CD45hi and microglia (CD45lo F480hi cells
in the retina; means 6 SD, n¼ 4–7 per time point). (B) The composition of CD45hi cell recruitment in the retina after STPT. Bar graphs represent
the means 6 SD for each subset of cells (*P < 0.05, 1-way ANOVA). (C) The composition of monocytes as Ly6Chi and Ly6Clo subsets after STPT.
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FIGURE 3. Time-dependent changes in the recruitment of BM-derived CD45hi cells in the RPE-choroid. Mouse eyes were subjected to 10% DC
subthreshold micropulse laser and harvested at times indicated. Eyes were dissected and RPE-choroid was prepared for flow cytometry. (A)
Percentages of CD45hi and microglia (CD45lo F480hi cells in the RPE layer; means 6 SD, n¼4–7 per time point). (B) The composition of CD45hi cell
recruitment to the RPE layer after STPT. Bar graphs represent the means 6 SD for each subset of cells (*P < 0.05, 1-way ANOVA). (C) The
composition of monocytes as Ly6Chi and Ly6Clo subsets after STPT.
Bone Marrow Cell Recruitment Following Phototherapy IOVS j October 2017 j Vol. 58 j No. 12 j 5169
factor-1 [SDF-1]), and its receptor CXCR-4 are similarly hypoxia
regulated, we next examined mRNA expression for Cxcl12 and
Cxcr4. Within 2 hours of laser treatment, expression of Cxcl12
(Fig. 7E) and its receptor Cxcr4 (Fig. 7F) decreased in the NSR
and RPE-choroid. Cxcl12 mRNA increased at 4 hours in the
RPE-choroid. However, by 4 hours post laser, Cxcr4 returned to
normal baseline levels in NSR but was increased in the RPE-
choroid at 12 hours.
Micropulse Laser Induces a Time- and Tissue
Compartment–Dependent Change in mRNA
Expression of Key Cytokines
We next performed an extended time course of 12 hours to 2
weeks, and we observed an increase in Ccl2 mRNA in the RPE-
choroid but not in the NSR. Cxcr4 mRNA expression was
observed in the RPE-choroid at 24 hours. Il1b mRNA increased
in the RPE-choroid at 12 and 24 hours. IL6 mRNA increased in
the RPE-choroid but not the NSR at 12 hours. Ifng mRNA
decreased at 12 hours and then increased at 24 hours in the
RPE-choroid. Tnfa mRNA did not change over time following
SRPT (Fig. 8).
FIGURE 4. Time-dependent changes in the recruitment of BM Lineage
Scaþ progenitor cells in the NSR and the RPE-choroid. Mouse eyes were
subjected to 10% DC subthreshold micropulse laser, eyes were
harvested, and the NSRs or RPE-choroids were prepared for flow
cytometry. Percentages of LS cells (*P < 0.05, 1-way ANOVA for each
tissue).
FIGURE 5. Subthreshold micropulse laser stimulates BM cells to migrate to RPE layer of affected eyes of GFPþ chimeric mice. (A) Representative
binary images of flat-mounted posterior cups (neural retina removed) imaged under epifluorescence to detect GFP show the patterns of homing to
areas subjected to laser application in chimeric mice 14 days following SRPT. (B) Quantification of the area positive for eGFP shows a 10% DC is
sufficient for maximal effect. *P < 0.05 vs. 5% duty cycle; n ¼ 5 for each condition. (C) A continuous layer of RPE cells (Occludin-positive, red)
without evidence of BM cells at time zero. (D) Evidence of IB-4þ cells (green) associated with RPE cells (Occludin-positive, red) following SRPT at
12-hour time point. (E) CD45þ cells (green) associated with RPE cells at higher magnification at the 12-hour time point. Scale bars: 10 lm.
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DISCUSSION
The salient finding of this study is the demonstration, we
believe for the first time, that BM-derived cells can be locally
recruited to the retina, including the RPE layer, using SRPT. We
did not observe any histologic evidence of damage in the NSR
or RPE-choroid (Fig. 1). Using flow cytometry, we determined
that the primary cell type that responded early (within 24
hours) to SRPT were monocytes (primarily Ly6Chi) and other
CD11b cells, whereas microglia cells (IBA-1þ cells) increased
at 2 weeks. The early inflammatory cells reestablished their
homeostatic levels by 2 weeks, but microglia number
increased. In the RPE-choroid, neutrophils and monocytes
(Ly6Chi) were increased at the early time points, whereas
macrophages and microglial cells were increased at the later
time point of 2 weeks. These results are in keeping with our
observed increase in GFPþ cell localization to the RPE layer
observed in GFP chimeric mice and in the adoptive transfer
studies.
We also found that SRPT primed the RPE-choroid, resulting
in an increase in the expression for the molecular chaperones
Hspa1a, Hsp90aa1, and the small HSP. Cryab mRNA
expression and subsequently an increase in Hif1a, Cxcl12I,
and Cxcr4 mRNA was observed. Moreover, unlike the CW laser,
SRPT was inherently nondestructive. The stimulation to the
NSR and RPE-choroid could be considered as photochemical in
nature, with the resultant increase in mRNA for key reparative
proteins serving to protect the retina and RPE and signal
recruitment of BM-derived cells to the retina. While the precise
cascade of events remains unknown, we have observed unique
temporal events. This photochemical stimulation52–56 likely
induced mild oxidative stress, stimulating recruitment of BM-
derived microglia.60,61 Oxidative injury launches the necessary
inflammatory pathways, including microglial activation to
foster tissue repair.62 We also observed an induction of Hif1a
mRNA possibly due to laser-induced local hypoxia, which in
turn is followed by the increase in expression of hypoxia-
regulated Cxcl12 and Cxcr4 mRNAs. These events, we
postulate, set the stage for the next round of repair (and next
round of BM-derived cell recruitment). Two weeks post SRPT,
BM marrow-derived cells specifically home to the RPE-
choroid.63 The ultimate fate of the BM cells remains unclear
as the current study represents a short (2-week) time course.
In the current study, we focused on the 10% DC, chosen
because at this DC BM-derived cell mobilization to the RPE was
maximal. This raises the possibility of a therapeutic ‘‘sweet
spot’’ in terms of future clinical applications. Micropulse laser
using a 5% DC has been demonstrated to be efficacious in the
treatment of DME.64,65 If there is a BM-derived stem cell
contribution to resolution of macular edema following
mircopulse laser, then perhaps a potentially greater benefit
may be observed if the 10% DC is employed rather than the
current 5%. Ultimately, this 10% vs. 5% DC therapeutic
quandary would require investigation within a clinical trial
framework because the current rodent model may not
accurately reflect the response of a diabetic macula to
micropulse laser. BM-derived reparative cells that home to
the retina and RPE likely promote their beneficial effect by
their paracrine production of growth factors and cytokines,
including those that can potentially reduce DME.66
The HSP response to photochemical stress was not
unexpected.52–56,67 Although there was no damage evident
to the NSR histologically, increased expression of these
proteins and IBA-1þ cell recruitment suggest the possibility of
some photochemical damage of the NSR overlying the RPE
treatment zone.52–56 It is also interesting to speculate that HSPs
and CXCL-12 may play a role in the resolution of DME
following micropulse laser therapy.38,64,65,67 Whereas the
mRNA expression of Hspa1a and Hsp90aa1 in the NSR and
the RPE-choroid tended to mirror each other, Cryab (a-
crystallin B) mRNA showed a marked increase at 2 hours in
the NSR but a decrease at each time point in the RPE. This
observation may signify that initially SRPT may shock or stun
the RPE, an effect that is reflected in the initial decrease in a-
crystallin B expression before recovery back toward baseline
levels. Alternatively, because a-crystallin B in some situations
can be a negative regulator of inflammation, in an acute
situation such as the laser model described herein, a temporary
downregulation of this small HSP may be essential to promote
the acute physiologic inflammatory response in the retina68–70
that we observed as microglia recruitment.
The acute reparative response we observed in our model is
in sharp contrast to the chronic inflammatory environment
that is the pathologic hallmark of both AMD and DR.71,72 In
these latter scenarios, the microglial response is inappropriate,
representing chronic activation, and is likely responsible for
upregulation of proinflammatory cytokines. Thus, our studies
support that the acute/physiologic versus chronic/pathologic
microglia activation is a key factor in determining the behavior
and fate of these cells and their role in disease. In the study by
Chidlow et al.,71 CW laser was compared with nonthermal
nanopulse laser in a rat model. They demonstrated colocaliza-
FIGURE 6. Adoptive transfer of BM stem cells following SRPT results in localization to the RPE layer. Eyes from WT mice that received intravenous
BM stem cells from GFPþ/þ transgenic mice immediately after 10% DC subthreshold micropulse laser and harvested 14 days later were
cryosectioned. GFP BM cells associated with RPE layer. The representative captured images shown are a merge of bright field and green (GFP) and
blue (DAPI) channels. Scale bar: 25 lm.
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tion of the inflammatory cytokines IL-1b and TNF-a with
microglia in both laser modes, with peak levels being observed
at the 6-hour time point.71 The nature of the IBA-1þ response is
likely dependent on the nature of the laser injury.73 A severe
laser injury may activate a pathologic microglial response,
defined as an exuberant acute inflammatory response charac-
terized by significant and prolonged microglial migration to the
outer segments and activation in the presence of excessive
proinflammatory cytokines. This would lead to destruction of
local tissue and/or excessive recruitment and deposition of
scar tissue. A less severe injury, such as one resulting from
micro- or nanopulse laser would likely induce an acute
inflammatory response that is self-modulating and self-limiting,
in that tissue repair will be complete and lead to normal return
of function and cellular homeostasis. Jobling et al.,74 in their
study to determine the effect of nanopulse laser in subjects
with bilateral intermediate AMD, proposed that one of the
possible mechanisms whereby nanopulse laser may be
beneficial was that there was no activation of the microglia
in the NSR.74 The implication is that microglial activation could
generate an exuberant and prolonged inflammatory response
similar to AMD and therefore promote progression of
disease.74,75
Inagaki et al.76 investigated the effects of sublethal laser
energy using an in vitro model where photocoagulation-like
areas were created in cultured ARPE-19 cell layers.76 Hsp70
mRNA expression was induced within 30 minutes of laser
irradiation, peaking at 3 hours after irradiation, which was
dependent on the number of laser pulses. Hsp70 protein
expression occurred concentrically around laser irradiation
sites and persisted for 24 hours following irradiation. They
concluded that sublethal photothermal stimulation with a
FIGURE 7. Time- and tissue compartment–dependent changes in mRNA expression of proteins involved in cell recruitment in GFP chimeric mice.
Mouse eyes were subjected to 10% DC subthreshold micropulse laser and harvested at the indicated time points. Eyes were dissected, mRNA was
extracted separately from NSR and RPE-choroid, and real-time PCR quantification was performed. All reactions were performed in triplicate. The
relative amounts of mRNAs were calculated using the 2DDCq method, using Actb as endogenous control. (A) Hsp1a1. (B) Hsp90aa1. (C) Cryab. (D)
Hif1a. (E) Cxcl12. (F) Cxcr4. Data are means 6 SEM; *P < 0.05 versus control, n¼ 5 mice per time point.
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micropulse laser may facilitate Hsp70 expression in the RPE
without inducing cellular damage.76
Based on the observations of the current study and those
of Jobling et al.,74 we can propose the concept of a laser-
induced therapeutic or inflammatory threshold. With a low-
dose pulse laser, the induced inflammatory response is below
an acute inflammatory threshold that gives rise to injury; it
rather represents a tempered physiological response. Where-
as with CW laser, regardless of whether it is visible or
subvisible, the inflammatory response is greater than the
threshold, a process that leads to inevitable destruction of the
NSR, which may be accompanied by excessive microglial
activation.
Nanopulse laser therapy has also demonstrated benefits in
both the treated and untreated eyes with nonexudative
AMD.74,77 When one considers that the current study
demonstrated mobilization of BM-derived cells and therefore
the potential for a systemic (and potentially) therapeutic
contribution to a local disease, then perhaps regression of
drusen and improvement in central retinal flicker threshold in
the fellow eye are not surprising findings from these studies, as
these cells would be expected to home to any site where
disease is present. Furthermore, it raises the tantalizing specter
of laser-guided mobilization and homing of BM-derived cells as
a viable therapeutic option in the management of disease, as
well as an option to guide stem cells following systemic
FIGURE 8. Time- and tissue compartment–dependent changes in mRNA expression of key cytokines in WT mice. Mouse eyes were subjected to 10%
DC subthreshold micropulse laser and harvested at indicated time points. Eyes were dissected, mRNA was extracted separately from NSR and RPE-
choroid, and real-time PCR quantification was performed. All reactions were performed in duplicate. The relative amounts of mRNAs were
calculated using the 2DDCq method, using Actb as endogenous control. (A) Cxcl2. (B) Cxcr4. (C) Il1b. (D) Il6. (E) Ifng. (F) Tnfa. Data are means 6
SEM; #P < 0.05 versus control; *P < 0.05 between NSR and RPE-choroid; n¼ 5 mice per time point.
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adoptive transfer, as we show. We recently showed that BM-
derived cells can be administered systemically and are directed
to the RPE layer where they integrate into the damaged RPE,
fostering repair.78
It is reasonable to envisage micropulse laser as more than
just a one-time therapy in that it should be possible to repeat
treatment when indicated. Furthermore, micropulse laser does
not have the side effects associated with CW laser.30,34–41 Our
results suggest that the therapeutic effect of micropulse
involves a systemic component, in addition to locally induced
effects. Although the precise mechanism of action of SRPT
remains unknown, the current study provides evidence that it
involves mobilization and recruitment of BM cells.
Although DME is part of a retinopathy that mainly involves
the inner blood retinal barrier, the beneficial effects of laser
that targets the RPE are long established.28–30,38 Despite this,
the precise mechanism of action of laser remains elusive.42–51
However, the limitations of this study must be acknowledged
as this laser model is neither a model of disease nor may it
accurately reflect the human retina. Increased expression of a-
crystallin B has been reported elsewhere to be essential for the
maintenance of vascular integrity in the retina via its
modulatory effects on VEGF function.79 Our studies would
also support laser-induced rejuvenation of microglia respond-
ing to CXCL-12 gradients as a potential contributor to the
beneficial mechanism of action.80 Micro- or nanopulse therapy
activates a tissue repair response.62
In the initial stages of micro- or nanopulse therapy, an
appropriate response (upregulation of HSPs, HIF1-a, and
CXCL-12, as well as infiltration of systemic immune cells,
including BM-derived cells) sets in motion the necessary train
of events to elicit repair. This response could repair macular
edema resulting from breakdown of the inner blood retinal
barrier or promote resolution of drusen and remodeling of
Bruch’s membrane in nonexudative AMD.38,67,71,72,74,81 With
the potential tissue benefits of SRPT as outlined here, this form
of laser may have benefits beyond the currently recognized
treatment of DME.30,64,82,83
Micropulse laser therapy can also be considered for the
treatment of macular edema occurring secondary to central
and branch retinal vein occlusion and even in the treatment of,
and as a possible alternative to, panretinal photocoagulation
for the treatment of proliferative retinopathies.84 In this latter
situation, SRPT, through augmentation of BM cells and the
association of the latter with the maintenance of vascular
integrity, may have a sufficient therapeutic benefit that does
not require photocoagulation of retinal tissue and instead
promotes repair.67 In addition, micropulse phototherapy
promotes resensitization of the retina to intravitreal anti-VEGF
therapy in individuals who have become refractory to this
treatment.85 This further begs the question whether this
beneficial action on the retina is all or in part due to BM cell
recruitment. Finally, and perhaps most importantly, and similar
to the observed benefits of nanopulse therapy in the treatment
of intermediate AMD, SRPT could provide an alternative
treatment modality that retards, arrests, or even rejuvenates
the retina without inducing retinal damage, even when used
unilaterally.74,77 This would be an era-defining breakthrough in
the treatment of nonexudative AMD, for which there is
currently no effective treatment. Elderly patients who are
afflicted with AMD typically have reduced levels of reparative
BM-derived CD34þ cells in their circulation.86–88 The use of
SRPT may facilitate the release of BM-derived cells into the
circulation followed by their homing to the site of laser
stimulation in the retina for the repair and maintenance of the
RPE, consequently promoting improved turnover of Bruch’s
membrane by the RPE. Investigation of SRPT in these various
clinical scenarios would require formal clinical trials.
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